Traumatic brain injury induces nociceptin/orphanin FQ expression in neurons of the rat cerebral cortex

Journal of Neurotrauma

Volumn 20, Issue 6, 2003, Pages 523-532

  Witta, Jassir ^a   Buzas, Beata ^a   Cox, Brian M ^a  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Brain; Enkephalin; Nociceptin; NOP receptor; ORL 1; Orphanin FQ; Traumatic injury

Indexed keywords

CASPASE 3; CELL MARKER; MESSENGER RNA; NEUROPEPTIDE; NOCICEPTIN; NOCICEPTIN RECEPTOR; NOP RECEPTOR; OPIATE; PROTEIN NEUN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN CORTEX; BRAIN INJURY; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; NERVE CELL DEGENERATION; NONHUMAN; PROTEIN LOCALIZATION; RAT; STAB WOUND;

EID: 0038721598     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/089771503767168456     Document Type: Article

References (29)

1. ALLAN, S.M., and ROTHWELL, N.J. (2001). Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2, 734-744.
2. ARMSTEAD, W.M. (2000). Role of NOC/oFQ in impaired opioid-induced pial artery dilation following brain injury. Brain Res. 869, 231-235.
3. BUZAS, B., ROSENBERGER, J., and COX, B. (1998). Activity and cAMP-dependent regulation of nociceptin/orphanin FQ gene expression in primary neuronal and astrocyte cultures. J. Neurochem. 71, 556-563.
4. BUZAS, B., SYMES, A., and COX, B. (1999). Regulation of nociceptin/orphanin FQ gene expression by neuropoietic cytokines and neurotrophic factors in neurons and astrocytes. J. Neurochem. 72, 1882-1889.
5. BUZAS, B., ROSENBERGER, J., KIM, K.W., et al. (2002). Inflammatory mediators increase the expression of nociceptin/orphanin FQ in rat astrocytes in culture. Glia. 39, 237-246.
6. CONNOR, M., VAUGHAN, C.W., CHIENG, B., et al. (1996a). Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br. J. Pharmacol. 119, 1614-1618.
7. 2+ in the SH-SY5Y human neuroblastoma cell line. Br. J. Pharmacol. 118, 205-207.
8. FADEN, A., MOLINEAUX, C., ROSENBERGER, J., et al. (1985). Endogenous opioid immunoreactivity in rat spinal cord following traumatic injury. Ann. Neurol. 17, 386-390.
9. HELYES, Z., NEMETH, J., PINTER, E., et al. (1997). Inhibition by nociceptin of neurogenic inflammation and the release of SP and CGRP from sensory nerve terminals. Br. J. Pharmacol. 121, 613-615.
10. JENCK, F., MOREAU, J.L., MARTIN, J.R., et al. (1997). Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress. Proc. Natl. Acad. Sci. USA 94, 14854-14858.
11. KING, M., CHANG, A., and PASTERNAK, G.W. (1998). Functional blockade of opioid analgesia by orphanin FQ/nociceptin. Biochem. Pharmacol. 55, 1537-1540.
12. KOSTER, A., MONTKOWSKI, A., SCHULZ, S., et al. (1999). Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. USA 96, 10444-10449.
13. LAUDENBACH, V., CALO, G., GUERRINI, R., et al. (2001). Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. J. Clin. Invest. 107, 457-466.
14. LEWEN, A., MATZ, P., and CHAN, P.H. (2000). Free radical pathways in CNS injury. J. Neurotrauma 17, 871-890.
15. LOU, L.G., ZHANG, Z., MA, L., et al. (1998). Nociceptin/orphanin FQ activates mitogen-activated protein kinase in Chinese hamster ovary cells expressing opioid receptor-like receptor. J. Neurochem. 70, 1316-1322.
16. LOVE, S. (1999). Oxidative stress in brain ischemia. Brain Pathol. 9, 119-131.
17. MANABE, T., NODA, Y., MAMIYA, T., et al. (1998). Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394, 577-581.
18. MATTHES, H., SEWARD, E.P., KIEFFER, B., et al. (1996). Functional selectivity of orphanin FQ for its receptor coexpressed with potassium channel subunits in Xenopus laevis oocytes. Mol. Pharmacol. 50, 447-450.
19. McINTOSH, T.K., HEAD, V.A., and FADEN, A.I. (1987). Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat. Brain Res. 425, 225-233.
20. MEUNIER, J.C., MOLLEREAU, C., TOLL, L., et al. (1995). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 377, 532-535.
21. MOGIL, J.S., and PASTERNAK, G.W. (2001). The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev. 53, 381-415.
22. NISHI, M., HOUTANI, T., NODA, Y., et al. (1997). Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphanin FQ receptor. EMBO J. 16, 1858-1864.
23. OYESIKU, N.M., EVANS, C.O., HOUSTON, S., et al. (1999). Regional changes in the expression of neurotrophic factors and their receptors following acute traumatic brain injury in the adult rat brain. Brain Res. 833, 161-172.
24. REINSCHEID, R.K., NOTHACKER, H.P., BOURSON, A., et al. (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270, 792-794.
25. ROSENBERGER, J., PETROVICS, G., and BUZAS, B. (2001). Oxidative stress induces proorphanin FQ and proenkephalin gene expression in astrocytes through p38-and ERK-MAP kinases and NF-kappaB. J. Neurochem. 79, 35-44.
26. SERHAN, C.N., FIERRO, I.M., CHIANG, N., et al. (2001). Cutting edge: nociceptin stimulates neutrophil chemotaxis and recruitment: inhibition by aspirin-triggered-15-epilipoxin a(4). J. Immunol. 166, 3650-3654.
27. TYURIN, V.A., TYURINA, Y.Y., BORISENKO, G.G., et al. (2000). Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. J. Neurochem. 75, 2178-2189.
28. VAN BREE, L., DASSESSE, D., and SCHIFFMANN, S.N. (1999). Changes in striatal neuropeptides and GAD67 expression following a minimal cortical lesion. Neuroreport 10, 2993-2997.
29. VAUGHAN, C.W., and CHRISTIE, M.J. (1997). Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J. Physiol. (Lond.) 498, 463-472.